Literature DB >> 3117465

Expression of HLA-D-locus (DP, DQ, DR)-coded antigens, beta 2-microglobulin, and the interleukin 2 receptor in Sjögren's syndrome.

R Jonsson1, L Klareskog, K Bäckman, A Tarkowski.   

Abstract

The expression of beta 2-microglobulin (beta 2m), class II major histocompatibility complex (MHC) antigens (HLA-DP, -DQ, -DR) and the interleukin 2 receptor (IL-2R) on resident and infiltrating cells in labial salivary glands of patients with Sjögren's syndrome (SS) was studied using an immunoperoxidase technique based on staining with monoclonal antibodies. The progression of the inflammatory process was accompanied by increasing numbers of immunocompetent cells as well as glandular epithelial cells expressing beta 2m and class II MHC antigens. Up to 60% of the infiltrating lymphocytes were DQ- and DR-positive while fewer cells stained for DP antigen. Glandular epithelium (acinar and ductal cells) stained for products of all three HLA-D subregions but with varying degrees of expression following the pattern DR greater than DP greater than DQ related to the severity of inflammation. A minor portion of the infiltrating lymphocytes expressed IL-2R. These findings emphasize the potential importance of epithelial expression of class II antigens in the local activation of T lymphocytes in salivary gland lesions of SS patients. They also indicate that differences may exist in this respect between T-cell reactions restricted by different class II MHC-encoded gene products.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117465     DOI: 10.1016/0090-1229(87)90038-9

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  8 in total

1.  Pancreatic ductal morphology and function in primary Sjögren's syndrome.

Authors:  E Lindström; F Lindström; H von Schenck; I Ihse
Journal:  Int J Pancreatol       Date:  1991-02

2.  Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome.

Authors:  J Krejsek; R Slezák; O Kopecky; V Derner; C Andrys
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

3.  Autoantibodies to novel membrane and cytosolic antigens of the lachrymal gland in primary Sjögren's syndrome.

Authors:  Peter Szodoray; Katalin Koczok; Antonia Szanto; Ildiko Fanny Horvath; Britt Nakken; Ildiko Molnar; Margit Zeher
Journal:  Clin Rheumatol       Date:  2007-08-23       Impact factor: 2.980

4.  Increased epithelial expression of HLA-DQ and HLA-DP molecules in salivary glands from patients with Sjögren's syndrome compared with obstructive sialadenitis.

Authors:  P S Thrane; T S Halstensen; H R Haanaes; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

Review 5.  The genetics of primary Sjögren's syndrome.

Authors:  Amr H Sawalha; Robyn Potts; Wendi R Schmid; R Hal Scofield; John B Harley
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

6.  Distribution of dendritic cells in normal human salivary glands.

Authors:  An Le; Michele Saverin; Arthur R Hand
Journal:  Acta Histochem Cytochem       Date:  2011-07-20       Impact factor: 1.938

7.  Long non-coding RNA expression profile in minor salivary gland of primary Sjögren's syndrome.

Authors:  Huan Shi; Ningning Cao; Yiping Pu; Lisong Xie; Lingyan Zheng; Chuangqi Yu
Journal:  Arthritis Res Ther       Date:  2016-05-17       Impact factor: 5.156

8.  Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome.

Authors:  Benjamin A Fisher; Roland Jonsson; Troy Daniels; Michele Bombardieri; Rachel M Brown; Peter Morgan; Stefano Bombardieri; Wan-Fai Ng; Athanasios G Tzioufas; Claudio Vitali; Pepe Shirlaw; Erlin Haacke; Sebastian Costa; Hendrika Bootsma; Valerie Devauchelle-Pensec; Timothy R Radstake; Xavier Mariette; Andrea Richards; Rebecca Stack; Simon J Bowman; Francesca Barone
Journal:  Ann Rheum Dis       Date:  2016-12-13       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.